Tag Archives: MRSA

MRSA genome sequencing leads to better understanding of disease severity

MRSA

Tweet Researchers at the University of Bath released study results on Thursday that revealed the genome sequence of methicillin-resistant Staphylococcus aureus, which may lead to personalized treatment for individual infections. “The standard approach has always been to focus on a … Read More »

Filed in Medical Countermeasures | Tagged , , | 2 Comments

CHP announces novel CA-MRSA case

MRSA

Tweet The Hong Kong Department of Health’s Centre for Health Protection announced on Thursday that it is currently investigating a novel case of pneumonia cause by community-associated Methicillin-Resistant Staphylococcus aureus. The patient is a 22-year-old male, considered to have a … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

FDA approves BD Diagnostics’ novel StaphSR Assay

BD-300x103

TweetBD Diagnostics, a subsidiary of Becton, Dickinson and Company, announced on Tuesday that it has received approval from the U.S. Food and Drug Administration to market its BD MAX StaphSR Assay. The BD MAX StaphSR Assay is part of BD … Read More »

Filed in Medical Countermeasures | Tagged , , | Comments Off

Nanosponge vaccine fights MRSA toxin

MRSA

Tweet Liangfang Zhang, a nanoengineering professor from the University of California San Diego, published a new study on Sunday in Nature Nanotechnology that showed a toxin produced by methicillin-resistant Staphylococcus aureus can be absorbed by nanosponges. Zhang said that when … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

MRSA cases increase by 20 percent in 2012

MRSA

Tweet The Statens Serum Institut said on Wednesday that the number of reported methicillin-resistant Staphylococcus aureus cases increased by 20 percent in 2012. A total of 1,556 new cases of MRSA were reported, the majority of which were people with … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

Prevention initiative reduces MRSA in veterans hospitals

MRSA

Tweet Five years after implementing an initiative to reduce methicillin-resistant Staphylococcus aureus in Veterans Affairs medical centers, MRSA cases are down, according to a study recently published in the American Journal of Infection Control. The MRSA Prevention Initiative was implemented … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

North Carolina researchers identify important gene in MRSA

Tweet University of North Carolina School of Medicine researchers recently pinpointed a gene that allows a drug-resistant bacterial strain to last longer on skin than other strains, which could lead to more effective treatments. A new strain of methicillin-resistant Staphylococcus … Read More »

Filed in Medical Countermeasures | Tagged | Comments Off

Fast DNA sequencing halts MSRA outbreak

Tweet Scientists recently used fast DNA sequencing technology to stop an outbreak of an infectious disease superbug in a hospital setting. The technique was used for the first time against an outbreak of Methicillin-resistant Staphylococcus aureus in a baby ward. … Read More »

Filed in Medical Countermeasures | Tagged | Comments Off

Study identifies MRSA in U.S. wastewater treatment plants

Compound increases antibiotic effectiveness against MSRA

Study determines best treatment timeline for MRSA-related pneumonia

Computer simulation shows hospitals’ MSRA rates are interconnected

MRSA infections decline in military personnel

British scientists trace spread of superbug through healthcare system

New test can rapidly detect MRSA

H1N1, MRSA co-infection increases mortality eight-fold in children

MRSA might be gaining antimicrobial resistance, study shows

MRSA levels hit record low in England

Drug-resistant strain of MRSA identified

FDA approves rapid MRSA test

MRSA screening can reduce costs for hospitals

Discovery made in search for MRSA vaccine

MRSA infections hitting Maine fishermen

Invasive MRSA may be in decline

Drug resistant child staph infection cases on the rise

Formulation used to fight bio-terrorism released for commercial use